حينما تجد الإشارة حمراء استعن بالصبر أداة من الأدوات..
و حينما تجدها خضراء.. تذكر..
تذكر إنها كانت.. و ستكون..
حمراء..
تذكر..
أن الشراكة البشرية..
إجبارية..
Dr. Bassem Matta has started Smiling Lungs Books, which combines his passions for medicine and literature. He holds degrees in biology and medicine from universities in Egypt and works as a certified medical assistant in the US. In addition to his medical career, Dr. Matta writes both medical and non-medical books under the pseudonym Matthew Japheth. Smiling Lungs Books publishes Dr. Matta's works as well as provides print-on-demand publishing services for others.
This certificate of completion was awarded to Bassem Matta for completing the 2024 FY Annual Training course on March 18, 2024 at VUMC. The certificate recognizes Bassem Matta's participation in and completion of the 2024 FY Annual Training course.
1) Joshua led the Israelites in conquering the Promised Land as commanded by God.
2) However, some lands still remained unconquered. Joshua gathered the tribes of Israel to remind them of God's commands and promises.
3) Joshua warned the people to remain faithful and obedient to God, and not to make alliances with the remaining pagan nations or adopt their religious practices.
حينما تجد الإشارة حمراء استعن بالصبر أداة من الأدوات..
و حينما تجدها خضراء.. تذكر..
تذكر إنها كانت.. و ستكون..
حمراء..
تذكر..
أن الشراكة البشرية..
إجبارية..
Dr. Bassem Matta has started Smiling Lungs Books, which combines his passions for medicine and literature. He holds degrees in biology and medicine from universities in Egypt and works as a certified medical assistant in the US. In addition to his medical career, Dr. Matta writes both medical and non-medical books under the pseudonym Matthew Japheth. Smiling Lungs Books publishes Dr. Matta's works as well as provides print-on-demand publishing services for others.
This certificate of completion was awarded to Bassem Matta for completing the 2024 FY Annual Training course on March 18, 2024 at VUMC. The certificate recognizes Bassem Matta's participation in and completion of the 2024 FY Annual Training course.
1) Joshua led the Israelites in conquering the Promised Land as commanded by God.
2) However, some lands still remained unconquered. Joshua gathered the tribes of Israel to remind them of God's commands and promises.
3) Joshua warned the people to remain faithful and obedient to God, and not to make alliances with the remaining pagan nations or adopt their religious practices.
This document discusses several topics:
- The nature and teachings of the prophet Abbakum and his prophecies.
- Moral lessons about following God's commandments and avoiding sinful behaviors.
- References to other prophets like Jeremiah and their messages about obeying religious authorities.
- The importance of faith, repentance from evil, and seeking forgiveness from God.
The document discusses several key points about the teachings of Jesus Christ:
1. It discusses the prophecy of Jesus by the prophet Thorasis and how Jesus came to fulfill this prophecy.
2. It describes how Jesus taught about loving one's neighbor and caring for the poor and less fortunate.
3. It talks about how Jesus performed miracles that demonstrated his power over nature and his authority as the son of God.
This document discusses Michelas Pipiprophetas and his teachings. It mentions that Michelas taught in Iotham, Iakob, Samaria and Iouda. It also discusses some of Michelas' followers and their spreading of his teachings, as well as reactions from others. The document references historical figures from around 150 BCE.
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...Jim Jacob Roy
In this presentation , SBP ( spontaneous bacterial peritonitis ) , which is a common complication in patients with cirrhosis and ascites is described in detail.
The reference for this presentation is Sleisenger and Fordtran's Gastrointestinal and Liver Disease Textbook ( 11th edition ).
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
CLASSIFICATION OF H1 ANTIHISTAMINICS-
FIRST GENERATION ANTIHISTAMINICS-
1)HIGHLY SEDATIVE-DIPHENHYDRAMINE,DIMENHYDRINATE,PROMETHAZINE,HYDROXYZINE 2)MODERATELY SEDATIVE- PHENARIMINE,CYPROHEPTADINE, MECLIZINE,CINNARIZINE
3)MILD SEDATIVE-CHLORPHENIRAMINE,DEXCHLORPHENIRAMINE
TRIPROLIDINE,CLEMASTINE
SECOND GENERATION ANTIHISTAMINICS-FEXOFENADINE,
LORATADINE,DESLORATADINE,CETIRIZINE,LEVOCETIRIZINE,
AZELASTINE,MIZOLASTINE,EBASTINE,RUPATADINE. Mechanism of action of 2nd generation antihistaminics-
These drugs competitively antagonize actions of
histamine at the H1 receptors.
Pharmacological actions-
Antagonism of histamine-The H1 antagonists effectively block histamine induced bronchoconstriction, contraction of intestinal and other smooth muscle and triple response especially wheal, flare and itch. Constriction of larger blood vessel by histamine is also antagonized.
2) Antiallergic actions-Many manifestations of immediate hypersensitivity (type I reactions)are suppressed. Urticaria, itching and angioedema are well controlled.3) CNS action-The older antihistamines produce variable degree of CNS depression.But in case of 2nd gen antihistaminics there is less CNS depressant property as these cross BBB to significantly lesser extent.
4) Anticholinergic action- many H1 blockers
in addition antagonize muscarinic actions of ACh. BUT IN 2ND gen histaminics there is Higher H1 selectivitiy : no anticholinergic side effects
Dr. Tan's Balance Method.pdf (From Academy of Oriental Medicine at Austin)GeorgeKieling1
Home
Organization
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
About AOMA: The Academy of Oriental Medicine at Austin offers a masters-level graduate program in acupuncture and Oriental medicine, preparing its students for careers as skilled, professional practitioners. AOMA is known for its internationally recognized faculty, award-winning student clinical internship program, and herbal medicine program. Since its founding in 1993, AOMA has grown rapidly in size and reputation, drawing students from around the nation and faculty from around the world. AOMA also conducts more than 20,000 patient visits annually in its student and professional clinics. AOMA collaborates with Western healthcare institutions including the Seton Family of Hospitals, and gives back to the community through partnerships with nonprofit organizations and by providing free and reduced price treatments to people who cannot afford them. The Academy of Oriental Medicine at Austin is located at 2700 West Anderson Lane. AOMA also serves patients and retail customers at its south Austin location, 4701 West Gate Blvd. For more information see www.aoma.edu or call 512-492-303434.
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
BBB and BCF
control the entry of compounds into the brain and
regulate brain homeostasis.
restricts access to brain cells of blood–borne compounds and
facilitates nutrients essential for normal metabolism to reach brain cells
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Pictorial and detailed description of patellar instability with sign and symptoms and how to diagnose , what investigations you should go with and how to approach with treatment options . I have presented this slide in my 2nd year junior residency in orthopedics at LLRM medical college Meerut and got good reviews for it
After getting it read you will definitely understand the topic.
Allopurinol, a uric acid synthesis inhibitor acts by inhibiting Xanthine oxidase competitively as well as non- competitively, Whereas Oxypurinol is a non-competitive inhibitor of xanthine oxidase.
Gene therapy can be broadly defined as the transfer of genetic material to cure a disease or at least to improve the clinical status of a patient.
One of the basic concepts of gene therapy is to transform viruses into genetic shuttles, which will deliver the gene of interest into the target cells.
Safe methods have been devised to do this, using several viral and non-viral vectors.
In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The biggest hurdle faced by medical research in gene therapy is the availability of effective gene-carrying vectors that meet all of the following criteria:
Protection of transgene or genetic cargo from degradative action of systemic and endonucleases,
Delivery of genetic material to the target site, i.e., either cell cytoplasm or nucleus,
Low potential of triggering unwanted immune responses or genotoxicity,
Economical and feasible availability for patients .
Viruses are naturally evolved vehicles that efficiently transfer their genes into host cells.
Choice of viral vector is dependent on gene transfer efficiency, capacity to carry foreign genes, toxicity, stability, immune responses towards viral antigens and potential viral recombination.
There are a wide variety of vectors used to deliver DNA or oligo nucleotides into mammalian cells, either in vitro or in vivo.
The most common vector system based on retroviruses, adenoviruses, herpes simplex viruses, adeno associated viruses.
Storyboard on Skin- Innovative Learning (M-pharm) 2nd sem. (Cosmetics)MuskanShingari
Skin is the largest organ of the human body, serving crucial functions that include protection, sensation, regulation, and synthesis. Structurally, it consists of three main layers: the epidermis, dermis, and hypodermis (subcutaneous layer).
1. **Epidermis**: The outermost layer primarily composed of epithelial cells called keratinocytes. It provides a protective barrier against environmental factors, pathogens, and UV radiation.
2. **Dermis**: Located beneath the epidermis, the dermis contains connective tissue, blood vessels, hair follicles, and sweat glands. It plays a vital role in supporting and nourishing the epidermis, regulating body temperature, and housing sensory receptors for touch, pressure, temperature, and pain.
3. **Hypodermis**: Also known as the subcutaneous layer, it consists of fat and connective tissue that anchors the skin to underlying structures like muscles and bones. It provides insulation, cushioning, and energy storage.
Skin performs essential functions such as regulating body temperature through sweat production and blood flow control, synthesizing vitamin D when exposed to sunlight, and serving as a sensory interface with the external environment.
Maintaining skin health is crucial for overall well-being, involving proper hygiene, hydration, protection from sun exposure, and avoiding harmful substances. Skin conditions and diseases range from minor irritations to chronic disorders, emphasizing the importance of regular care and medical attention when needed.
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Pulm2012 7 13-12cloc
1. 10th Annual UC Davis
Pulmonary
and Critical
Care Conference
State of the Art in 2012
Friday-Saturday
July 13-14, 2012
Hyatt Regency
Sacramento, California
Scan for
Online Registration
Sponsored by:
Office of Continuing Medical Education
and
Division of Pulmonary, Critical Care
and Sleep Medicine
Department of Internal Medicine
2. faculty
course chair
Brian Morrissey, MD
Associate Professor of Clinical Internal Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
University of California Davis School of Medicine
course co-chairs
Nicholas S. Stollenwerk, MD Ken Y. Yoneda, MD
Assistant Clinical Professor Professor of Clinical Internal Medicine
Division of Pulmonary, Critical Care Division of Pulmonary, Critical Care
and Sleep Medicine and Sleep Medicine
University of California Davis Health System University of California Davis Health System
GUEST FACULTY
Gary Raff, MD Jeremiah Duby, PharmD, BCPS
Associate Professor of Surgery and Pediatrics Director, Pharmacy Critical Care Program
Department of Surgery Department of Pharmaceutical Services
Division of Cardiothoracic Surgery University of California Davis Health System
University of California Davis Health System
DIVISION OF PULMONARY, CRITICAL CARE AND SLEEP MEDICINE
Timothy E. Albertson, MD, MPH, PhD Susan Murin, MD, MSc
Professor of Medicine, Pharmacology/ Professor of Clinical Internal Medicine
Toxicology and Anesthesia Vice Chair of Clinical Affairs,
Gordon A. Wong Professor in Pulmonary Department of Internal Medicine
and Critical Care Medicine Acting Chief, Division of Pulmonary, Critical
Acting Chair, Department of Internal Medicine Care and Sleep Medicine
Roblee P. Allen, MD Gibbe Parsons, MD
Professor of Clinical Internal Medicine Clinical Professor
Mark V. Avdalovic, MD Christian E. Sandrock, MD, MPH
Associate Professor of Clinical Internal Medicine Associate Professor of Clinical Internal Medicine
H. William Bonekat, DO Michael Schivo, MD
Clinical Professor Assistant Professor of Clinical Internal Medicine
Hugh B. Black, MD Christian Sebat, MD
Associate Clinical Professor Assistant Clinical Professor
Richart W. Harper, MD
Associate Professor of Medicine in Residence Post Doctoral Fellows
Jason Adams, MD
Nicholas J. Kenyon, MD Katherine Cayetano, MD
Associate Professor of Medicine in Residence Charles Poon, MD
Will Tseng, DO
Samuel Louie, MD
Professor of Clinical Internal Medicine
CONFERENCE COORDINATOR
Larry Jacinth
Meeting Planner
Office of Continuing Medical Education
University of California Davis Health System
3. 10th Annual UC Davis Pulmonar
State of the A
FRIDAY, July 13, 2012
9:00 am Registration, Refreshments, Visit Exhibits
10:00 Welcome and Course Objectives Brian Morrissey, MD
10:10 Lung Cancer Screening and Diagnosis
Introduction to Disease Screening Concepts Brian Morrissey, MD
CT Screening Ready for Prime Time: Pro and Con en Yoneda, MD; Susan Murin, MD
K
11:50 Update in Respiratory Infections Christian Sandrock, MD
Therapy
New Pathogens
12:30 pm Lunch (included in tuition)
1:30 Asthma
Update on Asthma Samuel Louie, MD
“Out of Control” Asthma
2:30 COPD
Where do These “New” Medications Fit? Michael Schivo, MD
What’s in the Diagnosis? Mark Avdalovic, MD
3:30 Pulmonary Case Poster Session and Refreshment Break
4:30 Pulmonary Case Review and Discussion
Panel: Roblee Allen, MD; Susan Murin, MD; Christian Sebat, MD
6:00 Adjourn
4. ry and Critical Care Conference:
Art in 2012
Saturday, July 14, 2012
7:00 am Registration, Continental Breakfast, Visit Exhibits
7:00 Sunrise Sessions – Roundtable Discussions:
Critical Care Journal Club Timothy Albertson, MD; Hugh Black, MD,
Brian Morrissey, MD; Nicholas Stollenwerk, MD
8:00 Critical Care Sessions— Nicholas Stollenwerk, MD
Welcome and Objectives
8:05 Delirium in the ICU Richart Harper, MD; Jeremiah Duby, PharmD
8:55 Q & A
9:05 Sepsis in 2012 Timothy Albertson, MD
9:50 Break, Visit Exhibits
10:05 Extracorporeal Life Support: Hugh Black, MD
What is it, who gets it….and does it work? Gary Raff, MD
11:15 Q&A
11:30 Lunch (on your own)
1:00 pm Small Group Sessions – Choose One
1. ECLS Workshop Hugh Black, MD; Gary Raff, MD
2. When Regular Mechanical Richart Harper, MD;
Ventilation “Fails” Katherine Cayetano, MD
3. Chest Radiography – Pearls and Review Gibbe Parsons, MD
4. Difficult Cases – Sleep H. William Bonekat, MD; Charles Poon, MD
5. Difficult Cases – Asthma,
Bronchial Thermoplasty and More Ken Yoneda, MD
1:55 Break, Transition into Workshops
2:00 Small Group Sessions (Repeated)
2:55 Break, Visit Exhibits
3:10 Small Group Sessions (Repeated)
4:00 Adjourn
Have a safe journey home!
5. TARGET AUDIENCE
This knowledge-based course continues to be developed with the busy practitioner in mind.
It is designed to improve the clinical practice of physicians, nurses, respiratory therapists,
and pharmacist through expanding knowledge, promoting collaboration, and fostering
interdisciplinary team management.
NEEDS ASSESSMENT
The UC Davis Pulmonary and Critical Care Conference, has reached its 10th Annual
presentation. Our program offers an evidence-based and state-of-the-art update on relevant
topics in Pulmonary, Critical Care, and Sleep Medicine. Highlighted topics are chosen based
on previous conference evaluations and a comprehensive needs assessment. We concentrate on
areas in medicine that are both clinically relevant and interesting, paying particular attention to
changes in clinical practice and technology. This activity is designed to enhance competency
through interactive didactic lectures and expert panel discussions, as well as through small
group workshops, case-based learning activities, and roundtable discussions. Our varied
learning formats make for a more interesting conference that better meets the needs of our
diverse audience. This conference will specifically address these identified educational needs.
In the area of critical care we will review the management of several areas of therapeutic
challenge: ARDS, delirium, and ICU infections. With increasing experience using extracorporeal
life support (ECLS) we have chosen to review the indications and implementation of this
technique. To better understand delirium in the ICU we will review the impact of sleep,
medications and withdrawal syndromes. For ICU infections, we will review new diagnostic
strategies and basic medical therapies. In the area of pulmonary disease, airway diseases and
cancer remain important causes of morbidity. This year’s conference provides an up-to-date
understanding of recent pharmacologic advances for airway disease management. We also
expand and review some of the new techniques such as bronco thermoplastic for the treatment
of asthma. We also review and update the topic of respiratory infections in the ever-growing list
of new and released to recognize pathogens. Using a stimulating pro-/con debate we address
the new CT screening data as it applies to lung cancer.
EDUCATIONAL OBJECTIVES
At the end of the program, participants should be able to:
• Describe the rational for the use of extracorporeal life support (ECLS)
• Identify the basic “anatomy” of the ECLS circuit and the team needed to support an
ECLS program
• Differentiate the risk and benefits of ECLS, and better identify which patients may
benefit from ECLS
• Explain current diagnostic and treatment strategies for infection in the ICU
• Discuss the state-of-the-art in recognition and treatment of sepsis
• Label recognition of delirium in the ICU
• Recognize risk factors and implement strategies to improve delirium in the ICU
• Name the effects of sleep disruption and sedation management in the ICU
• Appraise the evidence and controversy of CT screening for lung cancer
• Practice up to date, evidence based pharmacologic treatment strategies for asthma
and COPD
• Describe the similarities and differences in the pharmacologic treatment of asthma
and COPD
• Recognize patients who might benefit from bronchial thermoplasty for asthma
• Describe newly recognized respiratory pathogens
• Demonstrate evidenced based treatment strategies for respiratory infections
6. ENROLLMENT Please register early – space is limited.
Tuition is $355 for physicians and $305 for all others. Confirmation of registration will
be sent within two weeks after receipt of enrollment form. The fees will increase after
June 21, 2012.
Tuition includes continental breakfasts, refreshment breaks, one lunch, electronic syllabus, and
an online certificate of attendance. Tuition may be paid by check, American Express, Discover,
MasterCard or VISA. Cash is not accepted. The Office of Continuing Medical Education reserves
the right to cancel this program. In such a case, a full refund will be given.
Registration forms received without payments will not be processed until payment is
received, and payment must follow within 10 days. Early discount rates are honored if
payment is received by the date noted on the enrollment form. After that date, the late fee is applied.
Cancellation and Refund Policy:
A refund of tuition, less $75 administrative fee, will be allowed if requested in writing by June 21,
2012. No refunds will be provided after this date.
SYLLABUS
The electronic syllabus will be available to pre-registered attendees online prior to the meeting for
downloading and printing and onsite on a flash drive. Attendees will receive an email when the
syllabus materials are available online. Printed syllabus will not be available.
UC DAVIS HEALTH SYSTEM CME MISSION
In concert with the UC Davis Health System mission of “discovering and sharing knowledge to
advance health,” the continuing medical education (CME) mission focuses on the lifelong learning
commitments of healthcare professionals practicing in Northern California and beyond. UC Davis
CME is at the nexus between scientific discovery and its translation into practice. The CME program is
committed to developing evidence-based educational programs to meet the learners’ educational needs
to enhance competence, performance and/or patient care.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
As a provider accredited by the Accreditation Council for Continuing Medical Education, the
University of California, Davis Health System Office of Continuing Medical Education must ensure
balance, independence, and objectivity in all CME activities to promote improvements in health care
and not proprietary interests of a commercial interest. The provider controls all decisions related to
identification of CME needs, determination of educational objectives, selection and presentation of
content, selection of all persons and organizations that will be in a position to control the content,
selection of educational methods, and evaluation of the activity. Course directors, planning committee
members, presenters, authors, moderators, panel members, and others in a position to control the
content of this activity are required to disclose relevant financial relationships with commercial interests
related to the subject matter of this educational activity. Learners are able to assess the potential for
commercial bias in information when complete disclosure, resolution of conflicts of interest, and
acknowledgment of commercial support are provided prior to the activity. Informed learners are the
final safeguards in assuring that a CME activity is independent from commercial support. We believe
this mechanism contributes to the transparency and accountability of CME.
BROCHURE ART CREDIT
Brochure images courtesy of Accreditation Council for Continuing Medical Education,
Accreditation Council for Pharmacy Education, UC Davis Public Affairs, Hyatt Regency, and
rf123.com.
FOR FURTHER INFORMATION
UC Davis Health System 1(866) CME4EDU (263-4338)
Office of Continuing Medical Education (916) 734-5390
3560 Business Drive, Suite 130 (916) 734-0742 Fax
Sacramento, CA 95820-2161 http://cme.ucdavis.edu
7. ACCREDITATION
The University of California, Davis Health System is accredited by the
Accreditation Council for Continuing Medical Education (ACCME) to provide
continuing medical education for physicians.
Physician Credit: The University of California, Davis Health System designates this live activ-
ity for a maximum of 12 AMA PRA Category 1 Credits™. In addition, each optional breakfast
roundtable/workshop is designated for an additional 1 AMA PRA Category 1 Credits™. Physi-
cians should only claim credit commensurate with the extent of their participation in the activity.
AAFP: Application for CME credit has been filed with the American Academy of Family
Physicians. Determination of credit is pending.
AMA PRA Category 1 Credits™ acceptable for interprofessional team members
Nurse: For the purpose of recertification, the American Nurses Credentialing Center
accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME.
For the purpose of relicensure, the California Board of Registered Nursing accepts AMA
PRA Category 1 Credits™ (report hours of credit and fill in “CME Category 1” for the
provider number).
Physician Assistant: The National Commission on Certification of Physician Assistants
(NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical
education requirements for recertification.
Respiratory Therapist: This course meets the requirements for continuing education
for respiratory care practitioners in California.
ADDITIONAL CREDIT DESIGNATION
Pharmacist: The University of California Davis Health System Department of
Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a
provider of continuing pharmacy education. Pharmacist must attend the entire day to
receive full ACPE credit. No partial credit will be awarded.
July 13, 2012: ACPE Universal Activity Number 0277-0000-12-180-L01-P has been assigned to
this activity. This knowledge-based activity provides 6.00 contact hours (0.6 CEUs) of continuing
education credit.
July 14, 2012: ACPE Universal Activity Number 0277-0000-12-181-L01-P has been assigned to
this activity. This knowledge-based activity provides 6.00 contact hours (0.6 CEUs) of continuing
education credit.
General Session Optional Breakfast Roundtable Sessions
Up to 12 AMA PRA Category 1 Credits™ Up to 1 AMA PRA Category 1 Credits™
Cultural and Linguistic Competency Requirement
All continuing medical education (CME) courses with patient care components are required
by California State statute to include curriculum on cultural and linguistic competency in the
practice of medicine (California Business and Professions Code, Section 2190.1). Those who
have developed this UC Davis CME activity have been encouraged to address cultural and
linguistic differences for a diverse patient population related to this topic. A variety of resources
are available that address these competencies. Additional resources and information can be found
on our website, http://cme.ucdavis.edu.
8. location
Hyatt Regency Sacramento • 1209 L Street,, Sacramento, CA 95814
(916) 443-1234 • (916) 321-3099 Fax • http://www.Sacramento.Hyatt.com
HYATT REGENCY SACRAMENTO
A block of rooms is being held for conference participants at a rate of $125 single or double
occupancy plus hotel and sales tax (extension dates may be available). After June 21, 2012,
reservations will be on a space and rate available basis. Reservations should be made directly with
the hotel.
By staying at the host hotel, you help the University of California Davis meet its
contractual obligations with the Hyatt Regency Sacramento and keep future registration
fees reasonable. Please consider that when making your accommodation decisions. We
encourage you to stay at the host hotel.
The Hyatt Regency is across the street from the California State Capitol. It is near the K Street Mall,
Sacramento’s vibrant landmark shopping complex, and Old Sacramento, a national landmark and
California State Historic Park. “Old Sac” is a thriving commercial trade center and waterfront with
new public docks, excursion cruises, water taxi, some of Sacramento’s best restaurants, and the
famous Railroad Museum.
Layered clothing is recommended as the meeting room temperature may be uncomfortable
for some, depending on personal preferences. If you have any special needs due to a disability
as specified in the Americans with Disabilities Act, please call the Office of Continuing Medical
Education at (916) 734-5390 so we may make the necessary accommodations for you.
AIR TRAVEL to Sacramento International Airport (SMF)
United Airlines: Please call United Airlines at (800) 521-4041 between 7:00 am and 12:00 am
ET, to take advantage of this conference’s discounts by mentioning account code #552QB.
GROUND TRANSPORTATION
Hertz Car Rental: 1 (800) 654-2240 and request ID CV#04H70003 for discounted rates.
National Car Rental: 1 (800) CAR-RENT and request ID #5282865 for discounted rates.
http://supershuttle.com
9. ENROLLMENT APPLICATION PULMONARY AND CRITICAL CARE MEDICINE
(Please Print) July 13-14, 2012
________________________________________________________________________________________________
First Name MI Last Name
MD DO PharmD RPh PA NP RN Respiratory Therapist Lic.#________ Other___________
_________________________________________________________________________________________________
Institution/Employer (as you would like it to appear on your badge) Profession / Occupation
________________________________________________________________________________________________
Address (where you would like your receipt mailed)
________________________________________________________________________________________________
City State Zip Code
( ) ( )
________________________________________________________________________________________________
Day Phone Fax Number
________________________________________________________________________________________________
E-mail
E-mail for link to electronic syllabus. UC Davis CME will not use your email for any purpose other than corresponding with you.
Physician information required for CME credit and name badge. Please indicate primary medical specialty:
PULM CC FP GP IM Other (specify)____________________________________________________
Social Security Number (last 4 digits required for transcript purposes) PHARMACY CREDIT ONLY
10 Digit NABP ID# (ACPE)
X X X X X –––––––––––––––––––––––––––––––––––––
Month/day of birth Example Feb. 3 = 0203
–––––––––––––––––––––––––––––––––––––
Please copy the mail code from the address side of the brochure
(above your name, e.g. PPPUL, MMSPUL, CRDPUL)_ ________________________________________________________
If you did not receive a brochure in the mail, how did you hear about this conference?
(Example: PT&MG, UCD website, web search, magazine, friend)?_ ______________________________________________
cloc
WEB
Have you attended this conference in the past? Yes No
REGISTRATION FEES (Receipt/Confirmation will be mailed within two weeks)
Early Discount After June 21
Physician $355 $430
Other Health Care Professionals $305 $380
SYLLABUS
The electronic syllabus will be available to pre-registered attendees online prior to the meeting for downloading and
printing and onsite on a flash drive. Attendees will receive an email when the syllabus materials are available online.
No printed syllabus will be available.
If you need disability accommodations at the meeting, please let us know by July 1, 2012, and our representative will
contact you.
Please note special dietary/food allergy requirements
____________________________________________________
Registration forms received without check, credit card number or purchase order
number will not be processed until payment is received. For office use only
Check enclosed payable to: UC Regents PUL2013
AMEX Discover MasterCard VISA
6221
_________________________________________________________________________________________________
Account Number Expiration Date
_________________________________________________________________________________________________
Authorized Signature (name on card) Security Code
Please use ONE of these methods to register: (Do not mail if previously faxed or telephoned)
Mail application and payment: Office of Continuing Medical Education, c/o UC Davis Cashier’s Office
P.O. Box 989062, West Sacramento, CA 95798-9062
Telephone: (916) 734-5390 Fax application (916) 734-0742
Register online: http://cme.ucdavis.edu/conferences
10. University of California Davis
Office of Continuing Medical Education Non-profit Org.
3560 Business Drive, Suite 130 U.S. Postage
PAID
Sacramento, CA 95820-2161
Sacramento, CA
Permit No. 3405
10th Annual
If you cannot attend...
UC Davis Pulmonary and Critical Care Conference: please give brochure
State of the Art in 2012 to a colleague!
DATED MATERIAL
Friday-Saturday, July 13-14, 2012
Hyatt Regency, Sacramento, California
Highlights:
• Pro/Con: CT Screening for Lung Cancer
• Extracorporeal Support (“ECMO) in ARDS
• Bronchoscopy Updates: Thermoplasty for Asthma
This program is self-supporting and receives no state funding.